| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |